Clinical Trials

Prostate Cancer Study

CALGB 90203 Randomized Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy Versus Immediate Radical Prostatectomy In Patients With High-Risk, Clinically Localized Prostate Cancer

Protocol ID

08-004

Protocol Description

The purpose of this study is to compare the effects (good and bad) of the combination of chemotherapy and hormone therapy followed by radical prostatectomy (surgery to remove the prostate) with radical prostatectomy alone on patients and their prostate cancer to see which is better. This research is being done because many men with prostate cancer are at risk of having the cancer come back if they are treated only with surgery. We are trying to find out if giving chemotherapy with hormone therapy before surgery makes the chance of being cured of prostate cancer better. We are also going to study whether diet or lifestyle predicts how well patients do overall with prostate cancer.

Eligibility Criteria

Patients with prostate cancer at risk of cancer recurrence after surgery

Primary Investigator(s)

Bhoomi Mehrotra, MD

Contact Information

Dale Janson, RPA-C
(718) 470-4408
djanson@lij.edu

Last Update

March 29, 2010

top

Feinstein